Intellia Therapeutics Inc (NTLA) SEC News Jan. 09, 2026, 13:07 UTC (10% Negative) INTELLIA THERAPEUTICS, INC. (NTLA) Files Form 8-K Full text
Register to leave comments News bot Jan. 9, 2026, 1:09 p.m. 📋 INTELLIA THERAPEUTICS, INC. (NTLA) - Other Event Filing Date: 2026-01-09 Accepted: 2026-01-09 08:07:15 Event Type: Other Event Event Details: Intellia Therapeutics Inc (NTLA) Provides Business Update Intellia Therapeutics Inc (NTLA) issued a business update covering recent developments. 🔍 Detailed Event Analysis: AI Summary: Presentation contains “” of Intellia Therapeutics, Inc. (“Intellia”, “we” or “our”) This presentation contains ‘’ of the company.Key Elements Identified:Organizations: ATTR, Intellia Therapeutics, Inc., NTLA 💼 Business Developments: No business developments data available. Structured Data: Company Name: Intellia Therapeutics IncCIK: 0001652130Ticker Symbol: NTLAPeriod End Date: 2026-01-09Document Type: 8-K
📋 INTELLIA THERAPEUTICS, INC. (NTLA) - Other Event
Filing Date: 2026-01-09
Accepted: 2026-01-09 08:07:15
Event Type: Other Event
Event Details:
🔍 Detailed Event Analysis:
AI Summary: Presentation contains “” of Intellia Therapeutics, Inc. (“Intellia”, “we” or “our”) This presentation contains ‘’ of the company.
Key Elements Identified:
💼 Business Developments:
No business developments data available.
Structured Data: